ANIP vs. FDX

Last updated Apr 1, 2026

Compare and contrast key facts about ANI Pharmaceuticals, Inc. (ANIP) and FedEx Corporation (FDX).

Performance

ANIP vs. FDX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ANI Pharmaceuticals, Inc. (ANIP) and FedEx Corporation (FDX). The values are adjusted to include any dividend payments, if applicable.

ANIP vs. FDX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ANIP ANI Pharmaceuticals, Inc.	-2.58%	42.80%	0.25%	37.06%	-12.70%	58.68%	-52.91%	36.98%	-30.15%	6.32%
FDX FedEx Corporation	23.81%	5.11%	13.49%	49.13%	-31.64%	0.72%	74.27%	-4.78%	-34.67%	35.21%

Fundamentals

EPS ANIP : $3.75 FDX : $24.77
PE Ratio ANIP : 20.49 FDX : 14.38
PS Ratio ANIP : 1.82 FDX : 0.70
Total Revenue (TTM) ANIP : $883.37M FDX : $91.93B
Gross Profit (TTM) ANIP : $610.19M FDX : $22.44B
EBITDA (TTM) ANIP : $225.70M FDX : $10.48B

Returns By Period

In the year-to-date period, ANIP achieves a -2.58% return, which is significantly lower than FDX's 23.81% return. Over the past 10 years, ANIP has underperformed FDX with an annualized return of 8.52%, while FDX has yielded a comparatively higher 9.80% annualized return.

ANIP

• 1D: 4.33%
• 1M: 4.06%
• YTD: -2.58%
• 6M: -16.05%
• 1Y: 14.86%
• 3Y*: 24.63%
• 5Y*: 17.71%
• 10Y*: 8.52%

FDX

• 1D: 4.22%
• 1M: -7.59%
• YTD: 23.81%
• 6M: 52.44%
• 1Y: 49.35%
• 3Y*: 18.41%
• 5Y*: 6.73%
• 10Y*: 9.80%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ANIP vs. FDX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ANIP

ANIP Risk / Return Rank: 54
ANIP Sharpe Ratio Rank: 57
ANIP Sortino Ratio Rank: 54
ANIP Omega Ratio Rank: 52
ANIP Calmar Ratio Rank: 53
ANIP Martin Ratio Rank: 52

FDX

FDX Risk / Return Rank: 84
FDX Sharpe Ratio Rank: 86
FDX Sortino Ratio Rank: 82
FDX Omega Ratio Rank: 82
FDX Calmar Ratio Rank: 84
FDX Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ANIP vs. FDX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ANI Pharmaceuticals, Inc. (ANIP) and FedEx Corporation (FDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ANIP	FDX	Difference
Sharpe ratio Return per unit of total volatility	0.40	1.58	-1.17
Sortino ratio Return per unit of downside risk	0.93	2.16	-1.23
Omega ratio Gain probability vs. loss probability	1.11	1.30	-0.19
Calmar ratio Return relative to maximum drawdown	0.48	2.64	-2.16
Martin ratio Return relative to average drawdown	0.97	7.45	-6.48
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ANIP vs. FDX - Sharpe Ratio Comparison

The current ANIP Sharpe Ratio is 0.40, which is lower than the FDX Sharpe Ratio of 1.58. The chart below compares the historical Sharpe Ratios of ANIP and FDX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ANIP	FDX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.40	1.58	-1.17
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.38	0.21	+0.17
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.18	0.30	-0.13
Sharpe Ratio (All Time) Calculated using the full available price history	-0.05	0.41	-0.46

Correlation

The correlation between ANIP and FDX is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ANIP vs. FDX - Dividend Comparison

ANIP has not paid dividends to shareholders, while FDX's dividend yield for the trailing twelve months is around 1.63%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ANIP ANI Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
FDX FedEx Corporation	1.63%	1.98%	1.92%	1.95%	2.42%	1.12%	1.00%	1.72%	1.52%	0.76%	0.78%	0.64%

Drawdowns

ANIP vs. FDX - Drawdown Comparison

The maximum ANIP drawdown since its inception was -98.81%, which is greater than FDX's maximum drawdown of -71.32%. Use the drawdown chart below to compare losses from any high point for ANIP and FDX.

Drawdown Indicators

	ANIP	FDX	Difference
Max Drawdown Largest peak-to-trough decline	-98.81%	-71.32%	-27.49%
Max Drawdown (1Y) Largest decline over 1 year	-28.66%	-19.21%	-9.45%
Max Drawdown (5Y) Largest decline over 5 years	-59.38%	-53.70%	-5.68%
Max Drawdown (10Y) Largest decline over 10 years	-72.96%	-65.97%	-6.99%
Current Drawdown Current decline from peak	-82.91%	-7.94%	-74.97%
Average Drawdown Average peak-to-trough decline	-79.38%	-20.37%	-59.01%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.22%	6.80%	+7.42%

Volatility

ANIP vs. FDX - Volatility Comparison

ANI Pharmaceuticals, Inc. (ANIP) has a higher volatility of 9.44% compared to FedEx Corporation (FDX) at 8.12%. This indicates that ANIP's price experiences larger fluctuations and is considered to be riskier than FDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ANIP	FDX	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.44%	8.12%	+1.32%
Volatility (6M) Calculated over the trailing 6-month period	22.59%	17.91%	+4.68%
Volatility (1Y) Calculated over the trailing 1-year period	36.90%	31.49%	+5.41%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	47.10%	32.29%	+14.81%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	48.62%	32.55%	+16.07%

Financials

ANIP vs. FDX - Profitability Comparison

The chart below illustrates the profitability comparison between ANI Pharmaceuticals, Inc. and FedEx Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ANIP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, ANI Pharmaceuticals, Inc. reported a gross profit of 237.56M and revenue of 247.06M. Therefore, the gross margin over that period was 96.2%.

FDX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, FedEx Corporation reported a gross profit of 6.24B and revenue of 24.00B. Therefore, the gross margin over that period was 26.0%.

ANIP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, ANI Pharmaceuticals, Inc. reported an operating income of 48.18M and revenue of 247.06M, resulting in an operating margin of 19.5%.

FDX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, FedEx Corporation reported an operating income of 1.35B and revenue of 24.00B, resulting in an operating margin of 5.6%.

ANIP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, ANI Pharmaceuticals, Inc. reported a net income of 29.97M and revenue of 247.06M, resulting in a net margin of 12.1%.

FDX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, FedEx Corporation reported a net income of 1.06B and revenue of 24.00B, resulting in a net margin of 4.4%.